Evidence map›Paper›PMID 26499336›Full record

ArticleAIDS and behavior2016

Which Clinician Questions Elicit Accurate Disclosure of Antiretroviral Non-adherence When Talking to Patients?

Wynne Callon, Somnath Saha, P Todd Korthuis, Ira B Wilson, Richard D Moore, Jonathan Cohn, Mary Catherine Beach

Abstract read
In one paragraph

Article in AIDS and behavior, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Observational
  3. Article
  4. Article
  5. Advancing the Science and Practice of Medication Adherence.Journal of general internal medicine · 2018
    Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Wynne CallonJohns Hopkins University School of Medicine, Baltimore, MD, USA. wcallon1@jhmi.edu.
Somnath SahaPortland VA Medical Center, Portland, OR, USA.
P Todd KorthuisDepartment of Medicine, Oregon Health Sciences University, Portland, OR, USA.
Ira B WilsonDepartment of Health Services, Policy & Practice, Brown University School of Public Health, Providence, RI, USA.
Richard D MooreJohns Hopkins University School of Medicine, Baltimore, MD, USA.
Jonathan CohnDepartment of Medicine, Wayne State University, Detroit, MI, USA.
Mary Catherine BeachJohns Hopkins University School of Medicine, Baltimore, MD, USA.

Funding

Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Richard E. Chaisson · 2012 to 2026
$67.0M
Improving the diagnosis and treatment of medication adherence problems in HIVK24MH092242 · NIMH · BROWN UNIVERSITY · PI WILSON, IRA B · 2010 to 2014
$937k
Communication Quality and Patient Outcomes in HIV/AIDS and Substance AbuseK24DA037804 · NIDA · JOHNS HOPKINS UNIVERSITY · PI BEACH, MARY CATHERINE · 2015 to 2019
$923k
Quality Outcomes for Patients with Drug Abuse and HIVK23DA019809 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI KORTHUIS, PHILIP TODD · 2007 to 2011
$892k
NIAID NIH HHS P30 AI094189NIDA NIH HHS K23 DA019809NIDA NIH HHS K24 DA037804NIMH NIH HHS K24 MH092242
6 · The paper itself

Abstract

This study evaluated how clinicians assess antiretroviral (ARV) adherence in clinical encounters, and which questions elicit accurate responses. We conducted conversation analysis of audio-recorded encounters between 34 providers and 58 patients reporting ARV non-adherence in post-encounter interviews. Among 42 visits where adherence status was unknown by providers, 4 providers did not discuss ARVs (10 %), 6 discussed ARVs but did not elicit non-adherence disclosure (14 %), and 32 discussed ARVs which prompted disclosure (76 %). Questions were classified as: (1) clarification of medication ("Are you still taking the Combivir?"); (2) broad ("How's it going with your meds?"); (3) positively-framed ("Are you taking your medications regularly?"); (4) negatively-framed ("Have you missed any doses?"). Clinicians asked 75 ARV-related questions: 23 clarification, 12 broad, 17 positively-framed, and 23 negatively-framed. Negatively-framed questions were 3.8 times more likely to elicit accurate disclosure than all other question types (p < 0.0001). Providers can improve disclosure probability by asking directly about missed doses.

Indexed as

CommunicationDisclosureDrug MonitoringPhysician-Patient RelationsAdultAnti-HIV AgentsAttitude of Health PersonnelDrug CombinationsFemaleHIV InfectionsHumansInterviews as TopicLamivudineMaleMiddle AgedOffice VisitsAnti-HIV AgentsDrug CombinationsLamivudinelamivudine, zidovudine drug combinationZidovudineAdherenceAntiretroviralsHIV/AIDSPhysician-patient communication

Identifiers

PMID26499336
PMCPMC4840053

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.